Overexpression of Pituitary Adenylate Cyclase-Activating Polypeptide in Islets Inhibits Hyperinsulinemia and Islet Hyperplasia in Agouti Yellow Mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 2, 2004, Pages 796-803

  Tomimoto, Shuhei ^a   Hashimoto, Hitoshi ^a   Shintani, Norihito ^a   Yamamoto, Kyohei ^a   Kawabata, Yuki ^a   Hamagami, Ken Ichi ^a   Yamagata, Kazuya ^a   Miyagawa, Jun Ichiro ^a   Baba, Akemichi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI PROTEIN; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC MODEL; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERPHAGIA; INSULIN RELEASE; INSULIN SENSITIVITY; MATURITY ONSET DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NEUROTRANSMITTER RELEASE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; EATING; FEMALE; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; HYPERPLASIA; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; TRIGLYCERIDES;

EID: 2142694347     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.062919     Document Type: Article

References (40)

1. Arimura A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine and nervous systems. Jpn J Physiol 48:301-331.
2. Bertrand G, Puech R, Maisonnasse Y, Bockaert J, and Loubatieres Mariani MM (1996) Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat. Br J Pharmacol 117:764-770.
3. Buteau J, Roduit R, Susini S, and Prentki M (1999) Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42:856-864.
4. Chan CB, Wright GM, Wadowska DW, MacPhail RM, Ireland WP, and Sulston KW (1998) Ultrastructural and secretory heterogeneity of fa/fa (Zucker) rat islets. Mol Cell Endocrinol 136:119-129.
5. Ciani E, Hoffmann A, Schmidt P, Journot L, and Spengler D (1999) Induction of the PAC1-R (PACAP-type I receptor) gene by p53 and Zac. Brain Res Mol Brain Res 69:290-294.
6. Filipsson K, Kvist Reimer M, and Ahren B (2001) The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50:1959-1969.
7. Fridolf T, Sundler F, and Ahren B (1992) Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res 269:275-279.
8. Gray SL, Cummings KJ, Jirik FR, and Sherwood NM (2001) Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15:1739-1747.
9. Hamelink C, Tjurmina O, Damadzic R, Young WS, Weihe E, Lee HW, and Eiden LE (2002) Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci USA 99:461-466.
10. Hashimoto H, Hagihara N, Koga K, Yamamoto K, Shintani N, Tomimoto S, Mori W, Koyama Y, Matsuda T, and Baba A (2000) Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells. J Neurochem 74:501-507.
11. Hashimoto H, Shintani N, and Baba A (2002) Higher brain functions of PACAP and a homologous Drosophila memory gene amnesiac: insights from knockouts and mutants. Biochem Biophys Res Commun 297:427-432.
12. Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, Sakaue M, Miyazaki J, Niwa H, Tashiro F, et al. (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355-13360.
13. Hayek A and Woodside W (1979) Correlation between morphology and function in isolated islets of the Zucker rat. Diabetes 28:565-569.
14. Hosoya M, Kimura C, Ogi K, Ohkubo S, Miyamoto Y, Kugoh H, Shimizu M, Onda H, Oshimura M, Arimura A, et al. (1992) Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta 1129:199-206.
15. Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, et al. (2000) The cell cycle control gene ZAC/ PLAGL1 is imprinted-a strong candidate gene for transient neonatal diabetes. Hum Mol Genet 9:453-460.
16. Kieffer TJ and Habener JF (1999) The glucagon-like peptides. Endocr Rev 20:876-913.
17. Klinteberg KA, Karlsson S, and Ahren B (1996) Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells. Endocrinology 137:2791-2798.
18. Leech CA, Holz GG, and Habener JF (1996) Signal transduction of PACAP and GLP-1 in pancreatic beta cells. Ann NY Acad Sci 805:81-93.
19. Leibel RL, Chung WK, and Chua SC Jr (1997) The molecular genetics of rodent single gene obesities. J Biol Chem 272:31937-31940.
20. Like AA and Chick WL (1970) Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia 6:207-215.
21. Masuzaki H, Ogawa Y, Aizawa Abe M, Hosoda K, Suga J, Ebihara K, Satoh N, Iwai H, Inoue G, Nishimura H, et al. (1999) Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes 48:1615-1622.
22. Mizuno Y, Kondo K, Terashima Y, Arima H, Murase T, and Oiso Y (1998) Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: lack of evidence for involvement of hypothalamic neuropeptide gene expression. J Neuroendocrinol 10:611-616.
23. Nakata M, Shioda S, Oka Y, Maruyama I, and Yada T (1999) Insulinotropin PACAP potentiates insulin-stimulated glucose uptake in 3T3 L1 cells. Peptides 20:943-948.
24. Parker A, Meyer J, Lewitzky S, Rennich JS, Chan G, Thomas JD, Orho Melander M, Lehtovirta M, Forsblom C, Hyrkko A, et al. (2001) A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes 50:675-680.
25. Portela-Gomes GM, Lukinius A, Ljungberg O, Efendic S, Ahren B, and Abdel-Halim SM (2003) PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets. Regul Pept 113:31-39.
26. Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, and Pederson RA (2003) Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats. Diabetes 52:741-750.
27. 2+ elevation but not cyclic AMP in PACAP-induced p38 MAP kinase activation in PC12 cells. Regul Pept 109:149-153.
28. Sakai Y, Hashimoto H, Shintani N, Tomimoto S, Tanaka K, Ichibori A, Hirose M, and Baba A (2001) Involvement of p38 MAP kinase pathway in the synergistic activation of PACAP mRNA expression by NGF and PACAP in PC12h cells. Biochem Biophys Res Commun 285:656-661.
29. Sherwood NM, Krueckl SL, and McRory JE (2000) The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21:619-670.
30. Shintani N, Tomimoto S, Hashimoto H, Kawaguchi C, and Baba A (2003) Functional roles of the neuropeptide PACAP in brain and pancreas. Life Sci 74:337-343.
31. Straub SG and Sharp GW (1996) A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J Biol Chem 271:1660-1668.
32. Tamakawa H, Miyata A, Satoh K, Miyake Y, Matsuo H, Arimura A, and Kangawa K (1998) The augmentation of pituitary adenylate cyclase-activating polypeptide (PACAP) in streptozotocin-induced diabetic rats. Peptides 19:1497-1502.
33. Tams JW, Johnsen AH, and Fahrenkrug J (1999) Identification of pituitary adenylate cyclase-activating polypeptide1-38-binding factor in human plasma, as ceruloplasmin. Biochem J 341:271-276.
34. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, and Vaudry H (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324.
35. Wei Y and Mojsov S (1996) Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. J Neuroendocrinol 8:811-817.
36. Yada T, Sakurada M, Filipsson K, Kikuchi M, and Ahren B (2000) Intraperitoneal PACAP administration decreases blood glucose in GK rats and in normal and high fat diet mice. Ann NY Acad Sci 921:259-263.
37. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, and Kikuchi M (1994) Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem 269:1290-1293.
38. Yada T, Sakurada M, Ishihara H, Nakata M, Shioda S, Yaekura K, Hamakawa N, Yanagida K, Kikuchi M, and Oka Y (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats. J Physiol (Lond) 505:319-328.
39. Yamamoto K, Hashimoto H, Tomimoto S, Shintani N, Miyazaki J, Tashiro F, Aihara H, Nammo T, Li M, Yamagata K, et al. (2003) Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes. Diabetes 52:1155-1162.
40. Yokota C, Kawai K, Ohashi S, Watanabe Y, Suzuki S, and Yamashita K (1993) Stimulatory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on insulin and glucagon release from the isolated perfused rat pancreas. Acta Endocrinol (Copenh) 129:473-479.